Company Information

    Variantyx was founded on January 2014. The company is based in Framingham, MA, USA . The number of employees in Variantyx is less than 50. Variantyx offers a comprehensive set of advanced genomic diagnostic products and services with a focus on whole genome sequencing.
      If you are the founder or part of the founding team, please tell the world your story


          Funding & investors

          Variantyx has received 4 rounds of venture funding. The total funding amount is around $38M. Last venture funding round was $20M, announced on March, 2021.

            Similar Companies [beta]

              Venture Categories

                Active Venture Investors




                  Venture Competitors

                    News

                        Variantyx - Blog

                          • Variantyx Winter Holiday Hours of Operation

                          • Valued Customers, We would like to update you on our winter holiday hours of operation:  Our offices will be closed on December 24th in observance of Christmas Day and December 31st in observance of New Year’s Day. Variantyx will operate normally on all other days during the holiday season. To ensure the fresh transfer of […]The post Variantyx Winter Holiday Hours of Operation appeared first on Variantyx.
                          • ACMG secondary findings updated list for reporting of secondary findings, for medically actionable genes in clinical exome and genome sequencing

                          • ACMG secondary findings updated list for reporting of secondary findings, for medically actionable genes in clinical exome and genome sequencing.    The American College of Medical Genetics and Genomics (ACMG) recently published updated guidance for reporting secondary findings in the context of clinical exome and genome analyses1. This updated list now consists of 73 genes […]The post ACMG secondary findings updated list for reporting of secondary findings, for medically actionable genes in clinical exome and genome sequencing appeared first on Variantyx.
                          • Unavoidable vs optional incidental findings: What you need to know

                          • Given that genome sequencing has the potential to identify tens of thousands of variants in every patient sample tested, our GCs are often asked about how we handle incidental findings in our reporting. In this post we’ll explore the different types of possible findings and describe our reporting policies ...The post Unavoidable vs optional incidental findings: What you need to know appeared first on Variantyx.
                          • FXN: What you need to know for Friedreich’s ataxia patients

                          • It’s well known that FXN repeat expansions cause Friedreich’s ataxia, but in certain cases, the affected individual is compound heterozygous for an expansion plus another pathogenic variant.The post FXN: What you need to know for Friedreich’s ataxia patients appeared first on Variantyx.
                          • Is WGS-based testing relevant for patients with suspected mitochondrial disease?

                          • In short, yes! But let’s take a step back and start with what mitochondrial disease is. The post Is WGS-based testing relevant for patients with suspected mitochondrial disease? appeared first on Variantyx.
                          • Get to know the genes behind epilepsy

                          • Today we’re taking a look at some important epilepsy-related genes for which testing can be particularly tricky due to their propensity for deletion and/or duplication variants and tandem repeat expansions ...The post Get to know the genes behind epilepsy appeared first on Variantyx.

                          Share:     facebook    twitter    linkedin    reddit    email

                            Ventures Media is one of the largest startup and venture capital communities for startup and venture capital funding information and analysis.

                            Leave a Reply

                            Your email address will not be published. Required fields are marked *